GENOMIC VALLEY BIOTECH LIMITED (GVBL.BO)

INR 63.13

(1.66%)

Total Assets Summary of GENOMIC VALLEY BIOTECH LIMITED

  • GENOMIC VALLEY BIOTECH LIMITED's latest annual total assets in 2023 was 43.33 Million INR , down -1.96% from previous year.
  • GENOMIC VALLEY BIOTECH LIMITED's latest quarterly total assets in 2024 Q1 was - INR , down -100.0% from previous quarter.
  • GENOMIC VALLEY BIOTECH LIMITED reported annual total assets of 44.2 Million INR in 2022, up 16.41% from previous year.
  • GENOMIC VALLEY BIOTECH LIMITED reported annual total assets of 37.97 Million INR in 2021, down -50.15% from previous year.
  • GENOMIC VALLEY BIOTECH LIMITED reported quarterly total assets of - INR for 2023 Q3, down -100.0% from previous quarter.
  • GENOMIC VALLEY BIOTECH LIMITED reported quarterly total assets of 43.33 Million INR for 2023 FY, down -1.96% from previous quarter.

Annual Total Assets Chart of GENOMIC VALLEY BIOTECH LIMITED (2023 - 2019)

Historical Annual Total Assets of GENOMIC VALLEY BIOTECH LIMITED (2023 - 2019)

Year Total Assets Total Assets Growth
2023 43.33 Million INR -1.96%
2022 44.2 Million INR 16.41%
2021 37.97 Million INR -50.15%
2020 76.18 Million INR -4.85%
2019 80.06 Million INR 0.0%

Peer Total Assets Comparison of GENOMIC VALLEY BIOTECH LIMITED

Name Total Assets Total Assets Difference
Alfavision Overseas (India) Limited 1.78 Billion INR 97.573%
Biocon Limited 560.7 Billion INR 99.992%
Blue Jet Healthcare Limited 10.58 Billion INR 99.591%
Concord Biotech Limited 17 Billion INR 99.745%
Dishman Carbogen Amcis Limited 95.81 Billion INR 99.955%
FERMENTA BIOTECH LIMITED 5.47 Billion INR 99.209%
Lyka Labs Limited 1.56 Billion INR 97.235%
Panacea Biotec Limited 12.4 Billion INR 99.651%
SAMSRITA LABS LIMITED 155.51 Million INR 72.133%
Servoteach Industries Limited 1591.00 INR -2723767.002%
SMS Lifesciences India Limited 3.9 Billion INR 98.89%
Supriya Lifescience Limited 9.21 Billion INR 99.53%
Syngene International Limited 61.51 Billion INR 99.93%
TAKE Solutions Limited 881.05 Million INR 95.081%
Titan Biotech Limited 1.56 Billion INR 97.232%
Transgene Biotek Limited 324.4 Million INR 86.641%
Vanta Bioscience Limited 853.96 Million INR 94.925%